 |
|
|
| |
All-Oral Therapy With Sofosbuvir Plus
Ribavirin For the Treatment of HCV Genotype
1, 2, and 3 Infection in Patients Co-infected
With HIV (PHOTON-1)
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
Susanna Naggie1, Mark Sulkowski2, Jacob Lalezari3, W. Jeffrey Fessel4, Karam Mounzer5, Margaret Shuhart6, Annie Luetkemeyer7, David Asmuth8, Anuj Gaggar9, Liyun Ni9, Evguenia Svarovskaia9, Bill Symonds9, John McHutchison9, Douglas Dieterich10, Maribel Rodriguez-Torres11
1Duke Clinical Research Institute, Durham, NC, 2Johns Hopkins University, Baltimore, MD;; 3Quest Clinical Research, San Francisco, CA; 4Kaiser Permanente, San Francisco, CA; 5Philadelphia FIGHT, Philadelphia, PA; 6Harborview Medical Center, University of Washington, Seattle, WA; 7San Francisco General Hospital, University of California, San Francisco, CA; 8University of California Davis Medical Center in Sacramento, CA; 9Gilead Sciences, Foster City, CA; 10Mount Sinai School of Medicine, New York, NY, 11Fundacion De Investigacion San Juan, PR
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
|
| |
|
|
|
|
|
